Skip to content

TeleRehab trial

Development and a Randomized Open-Label Controlled Trial of Remote Cardiac Rehabilitation with Wearable Medical Devices-A multi center study - TeleRehab trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032250459
Enrollment
60
Registered
2025-10-28
Start date
2026-01-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular diseases Cardiovascular diseases

Interventions

Sponsors

Nakayama Atsuko
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with cardiovascular disesases after discharge 1) Obtained informed consent 2) Age 20-89 years old 3) Patients with cardiovascular disesases 4) Adhere to the schedule

Exclusion criteria

Exclusion criteria: 1) Acute myocardial infarction (within 2 days) 2) Before treatment for unstable angina 3) Pregnant or breastfeeding individuals 4) Uncontrolled arrhythmia 5) Symptomatic severe aortic stenosis 6) Uncontrolled symptomatic heart failure 7) Acute pulmonary embolism or pulmonary infarction 8) Acute myocarditis or pericarditis 9) Acute aortic dissection 10) Patients with difficulty walking 11) Psychiatric disorders that impair communication 12) Patients with a pacemaker or implantable cardioverter defibrillator (ICD) recently implanted 13) Patients deemed inappropriate for inclusion in the study by a investigator

Design outcomes

Primary

MeasureTime frame
changes in peak VO2

Secondary

MeasureTime frame
Total death, cardiovascular events, EF, e/e', BNP, CRP, VE-VCO2 slope, muscle volume (Inbody), EQ5D (QOL score), ICER

Contacts

Public ContactHiromi Shinoki

Sakakibara Heart Institute

tiken@shi.heart.or.jp+81-42-314-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026